# DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

> **NCT02478476** · — · UNKNOWN · sponsor: **OvaGene Oncology, Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Ovarian Neoplasms
- Fallopian Tube Neoplasms
- Peritoneal Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02478476
- **Lead sponsor:** OvaGene Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478476, "DNA Single Nucleotide Polymorphisms as Predictors of Toxicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02478476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*